0

studies recruiting now

as of 7 Sept 2026

0

studies registered in total

as of 7 Sept 2026

0

countries with a recruiting site

as of 7 Sept 2026

None

recruiting study posted to date

among recruiting studies

Recruiting trials

No registered studies found for PPoma.

ClinicalTrials.gov has no study listed under this name as of 7 Sept 2026. That can change, and there are other routes worth knowing about.

Keep watching

Get an email when a new PPoma study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About PPoma

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Treatments being studied

1 approved treatment and 11 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Belzutifan (Welireg)
Phase 3Everolimus (Afinitor)
Phase 3Somatostatin
Phase 2Capecitabine (Capecitabine)
Phase 2Palbociclib (Ibrance)
Phase 2Temozolomide (Temodal)
Phase 2Dactolisib
Phase 2Surufatinib
Phase 2Metformin

+ 3 more in development

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).